期刊
ACS CHEMICAL NEUROSCIENCE
卷 12, 期 10, 页码 1777-1790出版社
AMER CHEMICAL SOC
DOI: 10.1021/acschemneuro.0c00810
关键词
Oxycodone; diazepam; drug-drug interaction (DDI); pharmacokinetic-DDI; pharmacodynamic-DDI; physiologically based pharmacokinetics (PBPK); molecular docking; MD simulations
资金
- National Institutes of Health [ULITR001857]
- NIH [R01GM79383, P30 DA035778-01A1]
- NSF [1955260]
- Division Of Chemistry
- Direct For Mathematical & Physical Scien [1955260] Funding Source: National Science Foundation
This study utilized in silico pharmacokinetic and pharmacodynamic modeling to predict the drug-drug interaction between oxycodone and diazepam. The results suggest that diazepam may compete with oxycodone at the binding pocket of opioid receptors, leading to a synergistic effect between the two drugs.
Opioids and benzodiazepines have complex drug-drug interactions (DDIs), which serve as an important source of adverse drug effects. In this work, we predicted the DDI between oxycodone (OXY) and diazepam (DZP) in the human body by applying in silico pharmacokinetic (PK) and pharmacodynamic (PD) modeling and simulation. First, we studied the PK interaction between OXY and DZP with a physiologically based pharmacokinetic (PBPK) model. Second, we applied molecular modeling techniques including molecular docking, molecular dynamics (MD) simulation, and the molecular mechanics/Poisson-Boltzmann surface area (MM-PBSA) free energy method to predict the PD-DDI between these two drugs. The PK interaction between OXY and DZP predicted by the PBPK model was not obvious. No significant interaction was observed between the two drugs at normal doses, though very high doses of DZP demonstrated a non-negligible inhibitory effect on OXY metabolism. On the contrary, the molecular modeling study shows that DZP has potential to compete with OXY at the same binding pocket of the active mu-opioid receptor (MOR) and kappa-opioid receptor (KOR). MD simulation and MM-PBSA calculation results demonstrated that there is likely a synergetic effect between OXY and DZP binding to opioid receptors, as OXY is likely to target the active MOR while DZP selectively binds to the active KOR. Thus, pharmacokinetics contributes slightly to the DDI between OXY and DZP although an overdose of DZP has been brought to attention. Pharmacodynamics is likely to play a more important role than pharmacokinetics in revealing the mechanism of DDI between OXY and DZP.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据